Molecular Analysis for Metastatic Recurrence Risk

The lab analyst performs the technical lab tests for mRNA gene expression profiling for 11 genes and carries out an algorithmic analysis using patient data and the lab–test results to report a percentage risk for metastatic recurrence, and to evaluate the potential benefit of extended endocrine therapy. Choose a location to see hospital-reported price summaries. This page does not show national, sample, or aggregate pricing.